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Summary
AIMS: There is currently no centralised database on work-
ers’ exposures to plant protection products (PPPs) in
Switzerland, nor a national register for negative health
effects linking them to occupational PPP exposure. This
lack of basic data makes it difficult to implement either
epidemiological research or prevention campaigns for the
agricultural sector. The first objective was to understand
the level of information and flow of data on occupational
PPP exposures and health effects in the Canton of Vaud,
Switzerland. Then, to apply this information to develop
recommendations for improving a vigilance system for oc-
cupational health effects related to PPP exposure.
METHODS: A mapping study and semistructured stake-
holder interviews were conducted to better understand the
flow of data on occupational PPP exposures and health
effects. A clinical records investigation of workers occupa-
tionally exposed to PPPs was undertaken to understand
the magnitude of this potential problem. Finally, a work-
shop brought together relevant stakeholders to discuss
recommendations for the way forwards.
RESULTS: A lack of data on PPP exposures and associ-
ated health effects was revealed. This highlighted impor-
tant knowledge gaps at different levels of the current insti-
tutional information flow system. We found that although
there were numerous stakeholders that worked efficiently
in their own mandate, there was a clear need for increased
collaboration and coordination in order to make use of ex-
isting data to promote safer PPP use among agricultural
workers in Switzerland.
CONCLUSIONS: Due to increasing evidence of an as-
sociation between PPP exposure and health effects, in-
creased collaboration between stakeholders is necessary
to develop links between the data sources that already ex-
ist. Our study was the first to investigate the health ef-
fects linked to PPP exposure among the Swiss agricul-
tural population. The recommendations presented in this
paper would help promote a safer and healthier agricultur-
al workforce in Switzerland, as well as the population at
large.
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Introduction
Plant protection products (PPPs) are extensively used in
agriculture worldwide to control harmful pests and prevent
crop damage. PPP is a generic term that includes thousands
of different products used to prevent, destroy or control
harmful organisms or diseases, and to protect plants or
plant products during production, storage and transport [1].
The term PPP is a regulatory term often used interchange-
ably with “pesticide”; however, pesticide is a broader term
that also covers non-plant/crop uses, such as biocides and
veterinary drugs [1]. PPPs are only applied on plants or
crops and do not include biostimulants, which are regulat-
ed as fertilisers. Despite beneficial actions of PPPs for agri-
cultural production, their widespread use and inherent toxi-
city has posed long-recognised threats to human health [2].
Of potential PPP exposures, those that occur in the work-
place are of particular epidemiological importance because
of the likelihood of chronic exposures [3]. Agriculture in
every industrialised country is one of the most hazardous
occupations, on the basis of fatality and injury rates, as
well as illness rates [4]. From an occupational health per-
spective, chronic health effects, such as cancers and neu-
rodegenerative diseases, are more important than acute ef-
fects because of their severity, impact on the quality of life
of workers and their families, and their incurred costs to
the public health system. The association between occupa-
tional PPP exposures and chronic health effects has been
well documented, providing evidence of a positive associa-
tion between occupational exposure to PPPs and neurolog-
ical pathologies (including Parkinson’s disease), prostate
cancer and haematopoietic cancers (non-Hodgkin’s lym-
phoma and multiple myeloma) [2, 5–7].
Occupational PPP exposure in Switzerland
As in other countries, PPPs are widely used in Swiss agri-
culture to promote crop yield and quality, particularly on
vulnerable, but high profit, crops such as grapes used for
wine making and stone fruits (e.g., apricots in Wallis).
Almost 400 active substances are currently registered in
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Switzerland and are present in more than 1200 different
types of marketed PPPs [8]. Almost 2200 tons of active
substances are sold every year [9]. Despite knowledge of
the amounts of active substances sold, precise information
on the utilisation of active substances is limited. What
is known is that approximately 1.1 million workers are
affected by work-related health problems in Switzerland
[10]. In terms of the financial repercussions of occupation-
al exposures, this situation is not negligible. It is estimat-
ed that occupational disease costs amount to at least 3%
of the gross domestic product (equivalent to CHF 20 bil-
lion per year [10]). In 2003 there were 1000 deaths due to
occupational exposure to chemical products in Switzerland
[11]. However, a critical link between PPP use and sub-
sequent exposures, as well as potential incurred health ef-
fects among Swiss workers, is currently lacking. What are
the incidence rates for PPP-related disease among Swiss
agricultural workers? How can we know if an occupational
health risk exists among this population?
This lacuna of information may be a symptom of a lack of
attention to workplace health indicators, but it is also possi-
ble that it results from a more generalised problem of trans-
parency and health information management. According to
an Organization for Economic Co-operation and Develop-
ment (OECD) study, Switzerland is one of the countries
with the most limited health information systems [12]. Of
an analysis of health information systems across 22 OECD
countries, Switzerland ranked second to last in terms of
availability of health data. This study revealed that only
14% of health datasets are regularly linked or integrated
for research and statistics, highlighting the problem that
Switzerland lacks connections between different health in-
stitutions when it comes to data sharing and monitoring
[13].
There are several relevant bodies involved in the collection
of agricultural, occupational and public health data at the
federal, cantonal and local or private level in Switzerland
(fig. 1). Nevertheless, there is currently no centralised and
standardised database on workers’ exposures to PPPs, or
a national register of negative effects due to occupational
PPP exposure. This lack of knowledge makes it difficult
to design and implement epidemiological research, pro-
mote coordination among stakeholders, or to understand
the need for prevention efforts. As such, the objective
of this research was to better understand the state of the
knowledge regarding health effects due to occupational
PPP exposures in Switzerland. As part of this larger objec-
tive, an information flow map was developed to better de-
fine potential strategies for the improvement of a vigilance
system for PPP related health effects.
Figure 1: Overview of relevant stakeholders in Switzerland at the federal, cantonal, and local/private level with regard to collection of data on
agricultural workers, including PPP use and exposures, and occupational and public health indicators related to adverse health effects. These
stakeholders may be involved in PPP regulation and risk assessment (e.g., SECO, FOAG, FOPH), implement agricultural policies (e.g., SAVI,
Prometerre SA, SSP of VAUD, Agroscope), provide health insurance (e.g., SUVA, private insurance companies), provide education and advi-
sory services for workers (e.g., SPAA, SUVA, AGRIDEA, IST) as well as healthcare to patients (e.g., medical care providers, IST), or, conduct
research or gather/analyze existing data (e.g., IST, FOS). We contacted all the stakeholders presented in figure 1 for an interview.
Original article Swiss Med Wkly. 2018;148:w14610
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 2 of 9
Methods
Research was conducted between November 2016 and July
2017. Due to differences between cantons in regards to le-
gal mandates and health data protocols, we restricted re-
search to the canton of Vaud (Vaud). This canton was par-
ticularly interesting owing to the high concentration of
vineyards and orchards, and because it is home to one of
the region’s largest university hospitals (Lausanne Univer-
sity Hospital).
Mapping study and stakeholder interviews
As we were aware that a national database of information
on occupational PPPs exposure did not exist at the time of
undertaking the research, a mapping study was conduct-
ed because of its utility in reviewing multifaceted charac-
teristics of a research question [14]. Mapping focuses not
only on research findings, but also on qualitative descrip-
tors that reveal relationships and linkages between result-
ing data and information flow [14]. Our mapping study
consisted of iterative reviews of press and media articles,
as well as grey and peer-reviewed literature. In addition,
semistructured interviews were used to collect information
from stakeholders and took place between October 2016
and January 2017 (the stakeholder interview form is avail-
able in appendix 1). This first research phase sought to
identify linkages between the different stakeholders depict-
ed in figure 1 in order to comprehensively map existing in-
formation flow systems in regards to occupational PPP ex-
posure and health effects.
Clinical record investigation
The Institute for Work and Health (IST) provides spe-
cialised medical consultations for workers with health con-
cerns that may be linked to professional activity. IST oc-
cupational physicians conduct health examinations and
record the patient’s work history, which may be supple-
mented by analysis of safety data sheets and a workplace
visit. From the gathered information, the occupational
physician will determine the imputability of the pathology
to occupational exposures, suggest preventive workplace
measures together with an occupational hygienist, and ad-
vise workers on follow-up procedures such as a formal oc-
cupational disease claim to the relevant health insurance.
The IST medical department analysed patient files and pro-
vided an anonymous summary of all agricultural workers
who had visited the IST between April 1993 and January
2017 with a health concern and occupational exposure to
PPPs.
Stakeholder workshop
Based on information collected during the first research
phase, a stakeholder workshop was organised in which
focus group discussions could investigate more precisely
the research questions at hand. Workshop participants in-
cluded representatives of federal and cantonal authorities,
foundations, universities, family physicians and special-
ists, occupational physicians, private insurance companies,
SUVA (the Swiss National Accident Insurance Fund) and
agricultural organisations. The objectives of the workshop
were to: present the current situation and describe exam-
ples of registries used to collect data on the health effects
of PPPs; identify barriers in collecting occupational health
data; identify existing stakeholders that could develop a
registry on effects related to PPPs; and define recommen-
dations to improve the collection of PPP-related health ef-
fects.
Results and discussion
Overall, our investigations revealed that a significant lacu-
na of information currently exists for both exposure data
and health effect indicators related to occupational PPP ex-
posures in Switzerland. Consolidated results from the map-
ping study and stakeholder interviews (19 conducted in to-
tal) were used to map the informational flow related to PPP
exposure and health effects, and to better characterise the
barriers that exist for data collection and analysis. Results
revealed three distinct areas of importance: (1) occupation-
al PPP exposure scenarios; (2) reporting of PPP used; and
(3) reporting pathways of different PPP-related health ef-
fects (fig. 2).
Part 1: Occupational PPP exposure
Exposure is largely dependent on work tasks, and whether
an individual is an “operator” or a “worker”. Operators
handle, mix/load the PPPs; operate and repair application
machinery; and empty/clean machinery after use. Workers
are exposed when re-entering an agricultural area to con-
duct various tasks after PPP application, such as pruning
and harvesting. The main risks for PPP exposure are due
to noncompliance with protection requirements, such as
the lack, or incorrect use of personal protective equipment
(PPE). Results from the mapping study and stakeholder
interviews revealed that a majority of Swiss agricultural
workers do not take proper precautions for PPE use for a
variety of reasons [15]. PPE represents a significant cost to
farm owners, many of whom are not incentivised to pur-
chase or replace materials. In some cases, individual PPE
pieces may be purchased in lieu of an entire “PPE kit”.
These pieces may not always be well suited for the work
task, and can increase the exposure risk. PPE may also be
uncomfortable or burdensome, and some farmers are con-
cerned that PPE may harm the agriculture image among
the general population in regards to the use of toxic sub-
stances. Finally, interviews revealed that there is a gener-
ally low level of risk perception among agricultural work-
ers when it comes to PPP exposures. The Federal Office of
Statistics has retrievable data for number of employees in
agricultural operations by year and Canton, but this figure
is not defined for precise job-titles (owner vs operator vs
worker). Caution must be used when using job titles as ex-
posure surrogates because they may not be predictive for
PPP exposure [16].
Part 2: Reporting of PPPs used
It was not possible to quantify the amount of PPPs used
in Vaud for agricultural operations. However, it was pos-
sible to better understand where this information could be
retrieved. By federal mandate from the Federal Office of
Agriculture, each farm owner is required to keep a PPP
use diary (Journal d’Exploitation), which contains infor-
mation on the PPP applied, amount used and time of appli-
cation. Each farm operator must record PPP use data and
keep records for 6 years. Prometerre SA (Association vau-
doise de promotion des métiers de la terre) is mandated
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by the Service of Agriculture and Viticulture (SAVI) to in-
spect Vaud agricultural operations and PPP diaries. The re-
sults of the inspections are provided to SAVI, who estab-
lishes sanctions if necessary. In this way, farm operators
have a clear incentive to keep PPP diaries up to date. How-
ever, Prometerre SA does not treat the data in a way that
can be shared for informational purposes (e.g., volume of
PPPs used). The fact that PPP diaries are handwritten and
not digitised creates an additional barrier for data analysis
and sharing. It was revealed that, whereas SAVI maintains
a database with information on PPP use and application,
these data are not publicly accessible. Moreover, this data-
base does not contain any information on exposure or on
resulting health effects. Interviews with SAVI representa-
tives indicated that there is no known systematic mecha-
nism for reporting PPP-related health effects among farm-
ers.
Part 3: Reporting of PPP-related health effects
Potential health outcomes were grouped into three main
categories: poisonings; acute health effects; and chronic
disease. Information on PPP poisonings comes from the
national poison control centre, Tox Info Suisse, which has
a specific exposure category called “occupational”, as well
as a category for “agricultural/horticultural agents”. If
known, the product name and composition are recorded.
Since 1995, Tox Info Suisse received 1247 calls related
to occupational exposures with agricultural/horticultural
agents. However, PPPs are in the same category as manure
pit/silo gases, which are known to cause poisonings, and
whether these types of poisonings occur more frequently
than PPP poisonings should be investigated. Moreover, as
poisoning cases are voluntarily reported, underreporting
must be taken into consideration.
Aside from poisonings, the reporting of acute effects (e.g.,
dermal or respiratory irritations), and chronic diseases
(e.g., cancers or neurological diseases) was investigated. In
these scenarios, it is likely that workers consult their fam-
ily doctor or visit a clinic or hospital. Thus, it would be
most pertinent to contact local physicians, clinics and hos-
pitals to collect the health data. However, it was revealed
that in most cases, physicians do not collect a patient’s pro-
fession in a standardised way. Furthermore, general practi-
tioners (GPs) may not suspect that health effects are linked
to occupational exposure, and as such, there is generally no
systematic transfer of the patient to an occupational physi-
cian. Vaud does have an operating cancer registry and the
database records “occupation”, but it does not capture in-
formation related to work history, thus eliminating knowl-
edge of potential exposures. Unfortunately, it is foreseen
that the entrance of a new law [17] will altogether elim-
inate the practice of reporting profession in Swiss cancer
registries.
When a health effect is deemed to be caused by an occu-
pational exposure, the patient or physician can apply for a
work insurance claim. It is thus logical that insurance bod-
ies, such as SUVA, could have occupational health data.
However, these data provide only a small glimpse into the
Figure 2: Information flow diagram of the generalised process of occupational PPP exposures and resulting health effects. Part 1 demon-
strates occupational exposure scenarios; part 2 describes the reporting of PPP use; and part 3 traces the reporting pathway of different health
effects, from clinical assessment to insurance claims. *Translated from French (Journal d’exploitation; JE).
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problem, as approximately 80% of agricultural workers in
Switzerland work independently and therefore are not in-
sured by SUVA [18, 19]. Retrieving data from insurance
companies remains problematic as a result of a lack of pre-
cise recording mechanisms, and because of data privacy.
Clinical record investigation
From April 1993 and January 2017, six cases of adverse
health effects and occupational PPP exposures were report-
ed to IST: three cases of respiratory health effects, two
cases of neurological health effects, and one dermatologi-
cal health effect (table 1). Workers were concomitantly ex-
posed to multiple active substances (range: 2–12, average
6.5), making it difficult to ascertain a direct link between
exposure and resulting health effect. Evidence from epi-
demiological studies has shown occupational exposure to
PPPs to be associated with respiratory effects [20], neuro-
logical effects [21, 22], and dermatological effects [23, 24].
All cases were referred to IST via physicians, either gen-
eralists or specialists. There were three cases in which IST
advised patients to make an occupational disease claim.
Overall, the number of reported cases in 24 years com-
pared with the number of workers likely to be occupation-
ally exposed to PPPs in the French-speaking cantons of
Switzerland is very low. This highlights the need to collect
better data and to develop a standardised and centralised
registration system for exposed agricultural workers suf-
fering from PPP-related health effects.
Workshop results
A total of forty participants attended the one-day work-
shop. The attendance and active participation of numerous
stakeholders with different mandates represented a positive
result, providing evidence that this research question
marked an important issue for Swiss health research and
policy. To the authors’ knowledge, this workshop was first
time that such a broad stakeholder group was brought to-
gether to discuss the importance of improving the reporting
of PPP-related health effects for agricultural workers.
However, discussion during the workshop revealed that,
although there are numerous stakeholders that work ef-
ficiently in their own mandate, collaboration is limited,
especially when it comes to occupational exposures and
health indicators. This lack of collaboration hampers
knowledge exchange and linkages of potentially relevant
epidemiological data. It was emphasised that occupational
PPP exposure and determination of resulting health effects
is a cross-cutting issue, and therefore demands increased
collaboration between various institutional actors at the
federal, cantonal, and local levels. Workshop proceedings,
including a list of participants, can be accessed at:
http://www.i-s-t.ch/fileadmin/documents/Documents/1_-
_L_Institut/Ev%C3%A9nements/PesticideWorkshopRap-
port_Final_forupload_v2.pdf
Recommendations: the way forward
The collection, reporting and evaluation of occupational
health effects has the potential to improve the health and
safety of PPP users by reducing the likelihood of adverse
events, as well as to mitigate the consequences of such
events [25]. The European Food Safety Authority (EFSA)
defines this continuous process as “phytopharmacovigi-
lance”, which is distinct from monitoring and surveillance,
as it implies a process of close and constant attention,
specifically to post-marketing events related to PPP use
[25]. Phytopharmacovigilance can be used to identify
emerging PPP risks, estimate the magnitude of PPP related
health effects and evaluate the need for intervention and
prevention efforts. PPPs in Switzerland go through pre-
marketing authorisation procedures and include recom-
mendations for worker protection [15], but such protocols
do not address all environmental conditions, PPP mixtures,
chronic exposure patterns and other parameters that can
be encountered. As such, vigilance serves as a warning
system of effects not detected during the risk assessment
process. A well-documented vigilance system can estab-
lish routine medical follow-up of people at risk, and docu-
ment interventions and/or treatments as well as their effica-
cy. In turn, this critical information can inform the design
of preventive campaigns, guide policy decisions, and im-
prove the quality and performance of the public health sys-
tem. Improving the health of agricultural workers through
targeted prevention also makes economic sense by reduc-
ing the need for costly medical interventions necessary for
the treatment of chronic diseases.
Exploit existing data sources to enhance knowledge on
exposures
The first logical step towards effective phytopharmacovig-
ilance in Switzerland would be the assessment and ex-
ploitation of existing data sources to better characterise
PPP exposures, in order to more accurately predict health
effects. Existing modalities such as PPP diaries can be eas-
ily improved without developing a new and costly system.
PPP diaries can be collected and analysed systemically to
better understand the level of PPPs used in each region and
crop type. These data can be used to develop more accurate
occupational risk models, and would in turn inform target-
ed prevention strategies. To overcome the current limita-
tions of PPP diaries, their objective should be enlarged to
gather epidemiological exposure data, and they should be
digitalised and anonymised in order to ease centralisation
of data and reduce paperwork for farmers. Increased da-
ta on exposure indicators could provide the first steps to-
wards a more accurate assessment of potential health ef-
fects at the population level. In particular, with regional
information on exposures from PPP diaries, new linkages
could be made with local medical centres to better account
for related health effects. Such strategies, which adopt geo-
graphical information systems (GIS) methodologies, could
provide novel and specific data on PPP exposures and sub-
sequent disease – not only for human health but also for
environmental issues.
Develop epidemiological research studies on PPP-re-
lated health effects
One way to increase knowledge on PPP exposure and re-
lated health effects is to conduct targeted surveys on spe-
cific exposures and to investigate the potentially related
health problems among agricultural workers. Data from
the Swiss Health Survey and the Swiss Labour Force Sur-
vey could be linked to better assess health at the population
level by occupational activity and job tasks. In addition,
data from the Swiss General Population Census could be
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used to construct the first-ever Swiss cohort of agricultural
workers. Setting up such a prospective cohort would en-
able occupational epidemiologists to conduct cause-specif-
ic morbidity and mortality studies and to launch nested
case-control studies on specific diseases. With further im-
provement of data linkages, it should also be possible to
investigate specific sub-populations of this cohort, such as
spouses and children of workers. Linkage of this cohort
with data from cancer registries would provide an addition-
al valuable parameter for epidemiological cancer research.
Table 1: Medical consultation summaries of six patients reporting occupational exposure to PPPs and adverse health effects (assessed from all patient files at the Institute of
Work and Health from April 1993 to January 2017).
ExposureCase Patient details Work tasks
Product name Active substance (CAS
number)
Outcome Diagnosis
1 Horticulture appren-
tice, female, age 18
Watering plants;
transplanting; weed-
ing; making
seedbeds
Mapro®
Indar®
Fluazinam (CAS
79622-59-6)
Fenbuconazole (CAS
114369-43-6)
Emergency room visit
due to irritation of upper
airways and dyspnoea
Respiratory reaction due to allergy or irrita-
tion after inhalation of a fungicide. IST ad-
vised claiming for occupational illness, but
result unknown; work leave
2 Farmer, male, age
52
Production of cereal
crops
Exelor®
Round up®
Harmony sx®
Mecoprop-P-DMA (CAS
66423-09-4)
2,4-D DMA (CAS 2008-39-1)
4-chloro-2-methylphenol
(CAS 1570-64-5)
Glyphosate (CAS
1071-83-6)
Thifensulfuron methyl (CAS
79277-27-3)
Worsening of chronic
bronchitis. Skin rash fol-
lowing contact with milk-
ing cleansers or cows’
urine
Obstructive bronchopneumopathy. IST ad-
vised claiming for occupational illness, but
occupational illness not declared owing to
lack of insurance.
3 Farmer, male, age
54
Production of cereal
crops and potatoes
Fénican®
Banaril ®
Brasan Trio®
Diuron (CAS 330-54-1)
Terbuthylazine (CAS
5915-41-3)
Pendiméthaline (CAS
40487-42-1)
Chlorotoluron (CAS
15545-48-9)
Napropamide (CAS
15299-99-7)
Diméthachlore (CAS
50563-36-5)
Clomazone (CAS
81777-89-1)
Oxirane (methyl, polymer)
(CAS 75-21-8)
Chronic cough, nonspe-
cific bronchial reactivity.
Multifactorial chronic cough: organic dust
syndrome, gastro-oesophageal reflux, possi-
ble allergic contribution. Clinical improve-
ment since home heating with oil instead of
wood and treatment of gastro-oesophageal
reflux.
4 Farmer, male, age
49
Production of cereal
crops
Banvel-extra®
Omya Picobel-
lo®
Olymp 10 EW®
Banvel M®
MCPA DMA (CAS
2039-46-5)
Mecoprop-P-DMA (CAS
66423-09-4)
Dicamba-dimethylamine
(CAS 2300-66-5)
4-chloro-2-methylphenol
(CAS 1570-64-5)
Clopyralid (CAS 1702-17-6)
Triclopyr-butotyl (CAS
64700-56-7)
Flusilazole ISO (CAS
85509-19-9)
1,2-benzisothiazolin-3-one
(CAS 2634-33-5)
MCPA-K (CAS 5221-16-9)
MCPA (CAS 3653-48-3),
Dicamba-potassium
(CAS 10007-85-9)
Dicamba-sodium (CAS
1982-69-0)
4-chloro-2-methylphenol
(CAS 1570-64-5)
Polymyositis evolving for
4 years
No correspondence between pathology and
occupational exposures.
5 Horticulture worker,
male, age 19
Treatment of plants
with various PPPs
Marshal 25 EC®
Vertimec®
Apollo 50 SC®
Mapro®
Carbosulfan (CAS
55285-14-8)
Abamectine (CAS
65195-55-3)
Clofentezin (CAS
74115-24-5)
Fluazinam (CAS
79622-59-6)
Contact dermatitis of ex-
posed body parts after
working with phytosani-
tary agents
Professional contact dermatitis to phytosani-
tary agents; IST advice to declare occupa-
tional disease with insurer.
6 Gardener, male,
age 39
Treatment of plants
with various PPPs
Fux tril®
Garlon 3A®
Round up®
Zolone®
Dodene®
Veralin®
Triclopyr (CAS 55335-06-3)
Bendiocarb (CAS
22781-23-3)
Glyphosate (CAS
1071-83-6)
Phosalone (CAS 2310-17-0)
Tebuconazole (CAS
107534-96-3)
Bixafen (CAS 581809-46-3)
Diazinon (CAS 333-41-5)
Half body fluctuating
sensorimotor deficit.
First episode in the
spring of the consulta-
tion year
No accountability, no declaration of occupa-
tional disease.
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Such cohorts have existed for decades in several countries
[26, 27], attesting to their effectiveness as health surveil-
lance and epidemiological research infrastructure.
Emphasise occupational health among medical profes-
sionals
Accurate and standardised data on incidence and preva-
lence of health effects from a broad range of medical in-
stitutions is critical towards the operation of a successful
vigilance system. However, physicians – both GPs and
specialists – often do not collect the profession of patients,
or if they do, not in a standardised way. Any vigilance
system must therefore strengthen medical reporting efforts
through increased awareness among GPs. Targeted contin-
uing education should focus on occupational health indica-
tors in order to help GPs better recognise symptoms from
PPP exposures, and to emphasise the importance of refer-
rals to occupational physicians when in doubt. The im-
portance of incorporating occupational and environmental
health into primary care education and practice has been
long recognised in other countries [28].
Increase collaboration among stakeholders
A central obstacle remains the lack of coordination be-
tween institutional stakeholders when it comes to data
sharing and collaborative vigilance efforts. Indeed, this
barrier is not limited to Switzerland but rather represents
a trend of sectoral specialisation characteristic of modern
governments, in which organisations are governed by their
own priorities and operating mode [29]. Such situations of-
ten lead to departmentalism and the production of stand-
alone data that remain within an organisation’s policy silo
[30]. The incidence of PPP-related health outcomes repre-
sents a highly complex condition for public health and oc-
cupational health vigilance. In fact, the US Centers for Dis-
ease Control and Prevention recommends that phytophar-
macovigilance requires experts from a broad range of
backgrounds, including toxicology, epidemiology, medi-
cine, data management, occupational and environmental
health, occupational hygiene, integrated pest management
and health education [31]. This issue requires a shift from
traditional sectoral specialisation to a collaborative govern-
ment approach in order to be effectively addressed, and to
ensure that evidence-based decisions are made in order to
protect worker populations.
Bringing it all together
There is increasing evidence that PPP exposure may be as-
sociated with chronic neurodegenerative diseases and se-
lected cancers [2]. To address the burden of chronic dis-
ease nationwide, an increased focus on preventing its onset
as well as monitoring its progression is needed. Howev-
er, without an effective vigilance system and occupation-
al epidemiological research in place, there is a severely
limited understanding of this potential problem as well as
ways to mitigate adverse consequences at the population
level. This situation presents a unique dilemma, where the
lack of quantified evidence of a problem hampers politi-
cal will to establish a vigilance system. Such a vigilance
system is coincidentally the first step towards establishing
the magnitude of this potential occupational health prob-
lem for Swiss agricultural workers.
In September 2017, the Swiss Federal Council adopted
the Action Plan for Risk Reduction and Sustainable Use
of Plant Protection Products. The Action Plan proposes
that PPP related risks should be halved and alternatives
to chemical methods should be encouraged. The Federal
Council set clear objectives in this plan; now, appropriate
measures must be introduced to meet these objectives. The
recommendations of this investigation should be integrat-
ed into this action plan to promote the health and safety of
the Swiss agricultural workforce.
Finally, it important to highlight that these results extend
well beyond agricultural PPP exposures and occupational
health indicators. The widespread use of PPPs in Switzer-
land means that the general public is at risk for exposure,
including vulnerable populations such as pregnant women
and children. This is especially concerning given that a
high number of PPPs can be found in watercourses in
Switzerland [32]. As such, it is clear that the development
of an effective phytopharmacovigilance system would ben-
efit not only occupationally exposed workers, but also the
broader population.
Conclusion
There is a general lack of information concerning occupa-
tional PPP exposures and resulting health effects for Swiss
agricultural workers. Because of increasing evidence of a
potential link between PPP exposure and health effects, it
is imperative that increased research is conducted on this
topic in Switzerland. It is also crucial that stakeholders
from different fields of expertise coordinate actions to de-
velop a standardised and centralised system for collecting
health data of agricultural workers. Our study is the first
to investigate the health effects linked to PPP exposure
among the Swiss agricultural population. The recommen-
dations presented in this paper would help promote a safer
and healthier agricultural workforce in Switzerland, as
well as the population at large.
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Appendix 1
Semi-structured stakeholder interviews – in-
terview and recording form
Note: This interview form presents an outline of questions
to pose to stakeholders. However, given the semi-struc-
tured nature of this methodology, use the questions as a
way to guide the discussion, and allow the interview to
broaden its scope or perspective to develop pertinent ideas
and themes.
Interview form
Question / variable Response
1. Descriptive
1.1 Name of Interviewee
1.2 Institute
1.3 Position
1.4 Date
1.5 Interview location
2. Exposure information
2.1 In your opinion, which PPPs are of most interest for occupational exposures in
Switzerland?
2.2 Do you have information, data or research on the types and amounts of PPPs used
in Canton Vaud or Switzerland?
2.3 In your opinion, what types of crops are most pertinent for occupational PPP expo-
sures?
2.4 In your opinion, what types of tasks are most pertinent for occupational PPP expo-
sures?
2.5 What organisations or contacts would be pertinent to contact in order to obtain more
information, data or research on occupational PPP exposures in Switzerland?
3. Health effects
3.1 In your opinion, which health effects are the most important to consider following oc-
cupational PPP exposures in Switzerland?
3.2 Do you have information, data, or research on the health effects following occupa-
tional PPP exposure in Switzerland?
3.3 What organisations or contacts would be pertinent to contact in order to obtain more
information, data or research on the health effects following occupational PPP expo-
sures in Switzerland?
4. Additional information
4.1 What other information can be useful towards uncovering more information about
occupational PPP exposures and resulting health effects in Switzerland?
4.2 What are your recommendations in regards to the next steps for this research?
4.3 Any final comments, questions, suggestions?
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